REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 144 filers reported holding REVANCE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.20 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,972 | -56.3% | 695 | -3.5% | 0.00% | – |
| Q2 2023 | $18,223 | +86676.2% | 720 | +9.1% | 0.00% | – |
| Q1 2023 | $21 | +2000.0% | 660 | +1000.0% | 0.00% | – |
| Q4 2022 | $1 | -99.9% | 60 | +15.4% | 0.00% | – |
| Q3 2022 | $1,000 | -90.0% | 52 | -93.1% | 0.00% | – |
| Q4 2021 | $10,000 | -88.2% | 750 | -75.4% | 0.00% | -100.0% |
| Q3 2021 | $85,000 | -5.6% | 3,050 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $90,000 | +5.9% | 3,050 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $85,000 | +157.6% | 3,050 | +165.2% | 0.00% | – |
| Q4 2020 | $33,000 | -43.1% | 1,150 | -50.0% | 0.00% | – |
| Q3 2020 | $58,000 | +16.0% | 2,300 | +11.9% | 0.00% | – |
| Q2 2020 | $50,000 | +92.3% | 2,055 | +17.6% | 0.00% | – |
| Q1 2020 | $26,000 | -7.1% | 1,748 | 0.0% | 0.00% | – |
| Q4 2019 | $28,000 | -88.8% | 1,748 | -90.9% | 0.00% | -100.0% |
| Q3 2019 | $251,000 | – | 19,270 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,415,689 | $86,106,000 | 6.66% |
| Evolutionary Tree Capital Management, LLC | 176,336 | $3,439,000 | 2.39% |
| Essex Woodlands Management, Inc. | 457,085 | $8,913,000 | 2.16% |
| HealthCor Management, L.P. | 1,423,425 | $27,757,000 | 1.85% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,112,325 | $21,690,000 | 0.86% |
| Waypoint Capital Advisors, LLC | 53,989 | $1,016,000 | 0.60% |
| Antara Capital LP | 679,600 | $13,252,000 | 0.40% |
| Rhenman & Partners Asset Management AB | 198,358 | $3,868,000 | 0.38% |
| Walleye Capital LLC | 505,701 | $9,861,000 | 0.26% |
| Polar Capital Holdings Plc | 2,456,497 | $47,902,000 | 0.22% |